# Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection

> **NCT04491227** · — · UNKNOWN · sponsor: **University of California, San Diego** · enrollment: 2000 (estimated)

## Conditions studied

- Covid19
- AKI
- CKD
- ESRD
- Transplant;Failure,Kidney

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04491227
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-05
- **Primary completion:** 2022-04-30
- **Final completion:** 2023-03-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04491227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04491227, "Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04491227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*